The Clinical Operations team at Promontory Therapeutics is responsible for the planning, execution, and oversight of clinical trials for the company's investigational drug, PT-112. This team ensures compliance with regulatory requirements, manages relationships with clinical sites, and coordinates collaboration with partners like Pfizer and Merck KGaA. Their efforts are crucial in generating robust clinical data to evaluate the safety and efficacy of PT-112 across multiple phases of development.
View all